Expression profile of pattern recognition receptors in skeletal muscle of SOD1(G93A) amyotrophic lateral sclerosis (ALS) mice and sporadic ALS patients

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neuropathology and Applied Neurobiology

• Publication date

  2018-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/nan.12483PMID 29575052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle

  2018cited by this paper
• Low expression of IL-18 and IL-18 receptor in human skeletal muscle is associated with systemic and intramuscular lipid metabolism—Role of HIV lipodystrophy

  2018cited by this paper
• Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse

  2017cited by this paper
• The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice.

  2017cited by this paper
• Erratum to: Administration of 17β-Estradiol Improves Motoneuron Survival and Down-regulates Inflammasome Activation in Male SOD1(G93A) ALS Mice

  2017cited by this paper
• Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy

  2017cited by this paper
• ALS‐Associated Endoplasmic Reticulum Proteins in Denervated Skeletal Muscle: Implications for Motor Neuron Disease Pathology

  2017cited by this paper
• NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes

  2017cited by this paper
• Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune Recognition.

  2017cited by this paper
• Innate immune receptors in skeletal muscle metabolism

  2017cited by this paper
• Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice.

  2017cited by this paper
• Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis

  2017cited by this paper
• Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer

  2017cited by this paper
• The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury

  2016cited by this paper
• Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis

  2016cited by this paper
• Functional and Evolutionary Analyses Identify Proteolysis as a General Mechanism for NLRP1 Inflammasome Activation

  2016cited by this paper
• Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).

  2016cited by this paper
• The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients

  2016cited by this paper
• Post-translational regulation of inflammasomes

  2016cited by this paper
• There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.

  2016cited by this paper
• Mechanism and Regulation of NLRP3 Inflammasome Activation.

  2016cited by this paper
• TRIM11 Suppresses AIM2 Inflammasome by Degrading AIM2 via p62-Dependent Selective Autophagy.

  2016cited by this paper
• Administration of 17β-Estradiol Improves Motoneuron Survival and Down-regulates Inflammasome Activation in Male SOD1(G93A) ALS Mice

  2016cited by this paper
• The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

  2016cited by this paper
• Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling

  2015cited by this paper
• Activation and Regulation of NLRP3 Inflammasome by Intrathecal Application of SDF-1a in a Spinal Cord Injury Model

  2015cited by this paper
• The NLRP1 inflammasomes

  2015cited by this paper
• Lipidomic evidence that lowering the typical dietary palmitate to oleate ratio in humans decreases the leukocyte production of proinflammatory cytokines and muscle expression of redox-sensitive genes.

  2015cited by this paper
• AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3

  2015cited by this paper
• Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages

  2015cited by this paper
• Time-Point Dependent Activation of Autophagy and the UPS in SOD1G93A Mice Skeletal Muscle

  2015cited by this paper
• Amyotrophic lateral sclerosis: A Review

  2015cited by this paper
• Accumulation of STIM1 is associated with the degenerative muscle fibre phenotype in ALS and other neurogenic atrophies

  2015cited by this paper
• A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

  2015cited by this paper
• NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients

  2015cited by this paper
• Poststroke Inflammasome Expression and Regulation in the Peri-Infarct Area by Gonadal Steroids after Transient Focal Ischemia in the Rat Brain

  2015cited by this paper
• Amyotrophic Lateral Sclerosis: Review

  2015cited by this paper
• Advances in Nod-like receptors (NLR) biology.

  2014cited by this paper
• ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease

  2014cited by this paper
• Activation and Regulation of Cellular Inflammasomes: Gaps in Our Knowledge for Central Nervous System Injury

  2014cited by this paper
• Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations.

  2014cited by this paper
• Early Gene Expression Changes in Skeletal Muscle from SOD1G93A Amyotrophic Lateral Sclerosis Animal Model

  2014cited by this paper
• Mechanisms and functions of inflammasomes.

  2014cited by this paper
• Inflammasomes in neuroinflammation and changes in brain function: a focused review

  2014cited by this paper
• Cell Death-Associated Molecular-Pattern Molecules: Inflammatory Signaling and Control

  2014cited by this paper
• Pyroptotic Neuronal Cell Death Mediated by the AIM2 Inflammasome

  2014cited by this paper
• Inflammasomes in the CNS

  2014cited by this paper
• Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study

  2014cited by this paper
• NLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke

  2014cited by this paper
• Alcohol-Induced Liver Injury Is Modulated by Nlrp3 and Nlrc4 Inflammasomes in Mice

  2013cited by this paper
• Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

  2013cited by this paper
• Inflammation and neurovascular changes in amyotrophic lateral sclerosis.

  2013cited by this paper
• Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis.

  2013cited by this paper
• Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke

  2013cited by this paper
• Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset

  2013cited by this paper
• of amyotrophic lateral sclerosis

  2013cited by this paper
• Amyotrophic Lateral Sclerosis and Skeletal Muscle: An Update

  2013cited by this paper
• Defective Mitochondrial Dynamics Is an Early Event in Skeletal Muscle of an Amyotrophic Lateral Sclerosis Mouse Model

  2013cited by this paper
• Structure of the NLRP1 caspase recruitment domain suggests potential mechanisms for its association with procaspase‐1

  2013cited by this paper
• Interleukin-18 Activates Skeletal Muscle AMPK and Reduces Weight Gain and Insulin Resistance in Mice

  2013cited by this paper
• More than a bystander: the contributions of intrinsic skeletal muscle defects in motor neuron diseases

  2013cited by this paper
• Transcriptional analysis of the three Nlrp1 paralogs in mice

  2013cited by this paper
• Autolytic Proteolysis within the Function to Find Domain (FIIND) Is Required for NLRP1 Inflammasome Activity*

  2012cited by this paper
• NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells.

  2012cited by this paper
• Muscle Fiber Type-Dependent Differences in the Regulation of Protein Synthesis

  2012cited by this paper
• Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction

  2012cited by this paper
• The anabolic/androgenic steroid nandrolone exacerbates gene expression modifications induced by mutant SOD1 in muscles of mice models of amyotrophic lateral sclerosis

  2012cited by this paper
• Activation of the Nlrp1b Inflammasome by Reduction of Cytosolic ATP

  2012cited by this paper
• Mitochondrial dysfunction in ALS.

  2012cited by this paper
• NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice

  2012cited by this paper
• Amyotrophic lateral sclerosis.

  2012cited by this paper
• Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS.

  2012cited by this paper
• Anthrax Lethal Factor Cleavage of Nlrp1 Is Required for Activation of the Inflammasome

  2012cited by this paper
• Proteolytic Processing of Nlrp1b Is Required for Inflammasome Activity

  2012cited by this paper
• Caspase-1: is IL-1 just the tip of the ICEberg?

  2012cited by this paper
• Anthrax Lethal Factor Cleaves Mouse Nlrp1b in Both Toxin-Sensitive and Toxin-Resistant Macrophages

  2012cited by this paper
• Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons

  2011cited by this paper
• Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.

  2011cited by this paper
• Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology

  2011cited by this paper
• CARD8 and NLRP1 Undergo Autoproteolytic Processing through a ZU5-Like Domain

  2011cited by this paper
• Muscle atrophy induced by SOD1G93A expression does not involve the activation of caspase in the absence of denervation

  2011cited by this paper
• Skeletal muscle cells: from local inflammatory response to active immunity

  2011cited by this paper
• The Inflammasome Sensor, NLRP3, Regulates CNS Inflammation and Demyelination via Caspase-1 and Interleukin-18

  2010cited by this paper
• The inflammasomes.

  2010cited by this paper
• Signaling by ROS drives inflammasome activation

  2010cited by this paper
• Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing.

  2010cited by this paper
• Molecular Pathogenesis of Genetic and Inherited Diseases Inflammasome Up-Regulation and Activation in Dysferlin-Deficient Skeletal Muscle

  2010cited by this paper
• Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis

  2010cited by this paper
• Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.

  2010cited by this paper
• AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA

  2009cited by this paper
• An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome

  2009cited by this paper
• Muscle Mitochondrial Uncoupling Dismantles Neuromuscular Junction and Triggers Distal Degeneration of Motor Neurons

  2009cited by this paper
• Mechanism of Bcl-2 and Bcl-XL inhibition of NLRP1 inflammasome: Loop domain-dependent suppression of ATP binding and oligomerization

  2009cited by this paper
• Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice

  2009cited by this paper
• AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC

  2009cited by this paper
• Function of Nod‐like receptors in microbial recognition and host defense

  2009cited by this paper
• HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA

  2009cited by this paper
• Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model.

  2008cited by this paper
• A Molecular Platform in Neurons Regulates Inflammation after Spinal Cord Injury

  2008cited by this paper
• Skeletal muscle is a primary target of SOD1G93A-mediated toxicity.

  2008cited by this paper

• Roles of NLRC4 inflammasome in neurological disorders: Mechanisms, implications, and therapeutic potential.

  2025cites this paper
• Inflammasomes: novel therapeutic targets for metabolic syndrome?

  2025cites this paper
• A phase 2, proof-of-concept, placebo-controlled, randomized, multicenter, double-blind study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of Usnoflast (ZYIL1) in patients with amyotrophic lateral sclerosis

  2025cites this paper
• The Dual Role of Myokines in Fatigue Associated with Inflammatory Joint Diseases

  2025cites this paper
• Circulating miR-223/NLRP3 axis and IL-1β level in functional disease progression of amyotrophic lateral sclerosis

  2025cites this paper
• Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis

  2024cites this paper
• Inflammasomes in neurodegenerative diseases

  2024cites this paper
• Differentially expressed lncRNAs in SOD1G93A mice skeletal muscle: H19, Myhas and Neat1 as potential biomarkers in amyotrophic lateral sclerosis

  2024cites this paper
• From inflammatory signaling to neuronal damage: Exploring NLR inflammasomes in ageing neurological disorders

  2024cites this paper
• Elevated NLRP3 Inflammasome Activation Is Associated with Motor Neuron Degeneration in ALS

  2024cites this paper
• Inflammation in Metal-Induced Neurological Disorders and Neurodegenerative Diseases

  2024cites this paper
• Inflammasomes in neurological disorders — mechanisms and therapeutic potential

  2024cites this paper
• New insights into the function of the NLRP3 inflammasome in sarcopenia: mechanism and therapeutic strategies.

  2024cites this paper
• Eomesodermin expression in CD4+T‐cells associated with disease progression in amyotrophic lateral sclerosis

  2023cites this paper
• Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALS

  2023cites this paper
• Combining electromyography and Raman spectroscopy: optical EMG

  2023cites this paper
• Skeletal muscle as a molecular and cellular biomarker of disease progression in amyotrophic lateral sclerosis: a narrative review

  2023cites this paper
• Glial Cells and Brain Diseases: Inflammasomes as Relevant Pathological Entities

  2022cites this paper
• Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases

  2022cites this paper
• The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders

  2022cites this paper
• Catching a killer: Mechanisms of programmed cell death and immune activation in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Inflammasome in ALS Skeletal Muscle: NLRP3 as a Potential Biomarker

  2021cites this paper
• Neuronal accumulation of peroxidated lipids promotes demyelination and neurodegeneration through the activation of the microglial NLRP3 inflammasome

  2021cites this paper
• Walking down Skeletal Muscle Lane: From Inflammasome to Disease

  2021cites this paper
• Meet Our Editorial Board Member

  2021cites this paper
• Brain inflammasomes in depression

  2021cites this paper
• Discovery and characterization of small-molecule inhibitors of NLRP3 and NLRC4 inflammasomes

  2021cites this paper
• Expression and cell type-specific localization of inflammasome sensors in the spinal cord of SOD1(G93A) mice and sALS patients.

  2021cites this paper
• Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse Model

  2020cites this paper
• The IL-1 family cytokines and receptors in autoimmune diseases.

  2020cites this paper
• Neuroimmune Connections in Aging and Neurodegenerative Diseases.

  2020cites this paper
• Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss

  2019cites this paper
• Imaging Hypoxic Stress and the Treatment of Amyotrophic Lateral Sclerosis with Dimethyloxalylglycine in a Mice Model.

  2019cites this paper
• Inflammasomes in neuroinflammatory and neurodegenerative diseases

  2019cites this paper
• Relationship between Liver Pathology and Disease Progression in a Murine Model of Amyotrophic Lateral Sclerosis

  2018cites this paper